N03.5
Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis
Clinical Classification Guidelines
Inclusion Terms
- Chronic nephritic syndrome with membranoproliferative glomerulonephritis, types 1 and 3, or NOS
Excludes Type 1
- Chronic nephritic syndrome with C3 glomerulonephritis (N03.A)
- Chronic nephritic syndrome with C3 glomerulopathy (N03.A)
Medical Intelligence & Overview
Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis, classified under ICD-10 code N03.5, is a kidney disorder characterized by long-term inflammation affecting the glomeruli. These tiny filtering units within the kidneys play a crucial role in removing waste and excess fluids from your blood. When they become inflamed or damaged, it can impair kidney function, potentially leading to chronic kidney disease. This condition is often associated with specific types of glomerulonephritis, including membranoproliferative forms, which involve the abnormal proliferation of cells within the glomeruli and immune complex deposits, leading to scarring and damage.
Causes & Symptoms
Clinical Causes: Immune system disorders, such as systemic lupus erythematosus Infections, including hepatitis B and C Monoclonal gammopathies or blood cancers Genetic predispositions affecting immune regulation Certain drug exposures or toxins Other forms of glomerulonephritis that lead to immune complex deposits
Key Symptoms: Blood in the urine (hematuria) Protein in the urine (proteinuria) Swelling, especially in the legs, ankles, or face High blood pressure (hypertension) Fatigue and general weakness Foamy urine due to excess protein Decreased urine output in advanced stages
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of blood and urine tests, imaging studies, and often a kidney biopsy. Tests may reveal elevated levels of protein or blood in the urine, impaired kidney function, and abnormal immune markers. A biopsy provides a definitive diagnosis by examining a small tissue sample from the kidney under a microscope, identifying characteristic diffuse mesangiocapillary (or membranoproliferative) glomerulonephritis features such as thickened glomerular basement membranes and immune deposits.
Treatment Protocols: While specific treatments can vary based on individual cases, management typically aims to control symptoms, slow disease progression, and address underlying immune issues. Possible approaches include blood pressure medications like ACE inhibitors or ARBs, immunosuppressive drugs to reduce immune activity, and lifestyle modifications such as dietary adjustments. In advanced stages, dialysis or kidney transplantation may be necessary. Regular monitoring by healthcare providers is essential to adapt treatment plans and manage complications effectively.
Clinical Advice & FAQs
Billing Guidance
Is N03.5 a billable ICD-10 code?
Yes, N03.5 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report N03.5?
Clinical documentation must specify the nature of Chronic nephritic syndrome with diffuse mesangiocapillary glomerulonephritis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference